Publication | Closed Access

A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells

NanoparticlesNanomedicineDrug TargetingEngineeringMedicinePharmaceutical NanotechnologyBreast CancerAnti-cancer SynergyTumor TargetingBiomedical EngineeringNano-drug DeliveryPharmacology